$VSEC

CUOMO JOHN A sold $294K of VSEC

CUOMO JOHN A (CEO and President) sold 1,566 shares of VSE CORP (VSEC) at an average of $187.49 ($186.42–$188.88, $0.29M total) across 4 trades on 2026-09-14 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · CUOMO JOHN A
Published Sep 16, 2026, 8:35 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 16, 2026, 8:42 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$VSEC
Neutral
high confidence
Mentioned
$VSEC
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VSECNeutralLow
01

Why it matters

The CEO's sale is modest and executed under a pre‑arranged plan, suggesting limited informational value for traders.

02

Market read

A routine insider sale with modest size; low trading relevance.

03

What to watch

Potential upcoming corporate actions or financing needs not disclosed.

Relevance 3/10Novelty 4/10Timing: filed Sep 16, 2026 (post‑market)

Background

Form 4 filings provide transparent reporting of insider transactions required by the SEC.

Company-level read

Ticker impact

$VSECNeutralHigh confidence
Context

SEC Form 4 disclosed CEO John A. Cuomo sold 1,566 shares of VSEC for $293.6K via a 10b5‑1 plan.

Expected impact

Limited short‑term pressure; unlikely to move price materially.

Evidence & confidence

The filing is the first public disclosure of the transaction; size is under $1M, typical for routine 10b5‑1 sales.

Market effects

Minimal impact on the broader security services sector.

No discernible effect on regional markets.

Negligible on a global scale.

Counterpoint

The sale could be a routine liquidity event rather than a negative signal.

Key entities

  • VSE Corp

    Issuer of the securities sold.

  • John A. Cuomo

    CEO and President of VSE Corp.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$VSECMed

Guggenheim initiates VSE stock with neutral on margin concerns

Guggenheim initiated VSE Corporation (VSEC) with a neutral rating, citing margin concerns and the need for operational improvements. The company reported Q2 2026 earnings of $1.75 per share on $449.1M revenue, beating estimates. Stifel raised its price target to $260, maintaining a Buy rating. VSEC's EBITDA grew 98% YoY to $86M, with margins expanding to 19.2%.

$VSECMedAI 8/10

A Record Quarter Raises The Stakes For VSE Corp. (VSEC)

VSE Corporation (VSEC) reported Q2 revenue of $449.1M, up 65% YoY, with organic growth of 14%. Adjusted EBITDA rose to $86.0M, with a margin of 19.2%. The company completed two major acquisitions, raising full-year guidance. Debt increased to $966.7M, and free cash flow was negative $50.0M for H1 2026. The stock trades at 25x forward earnings.

$VSECMed

VSE (VSEC) Q2 2026 Earnings Call Transcript

VSE Corp (VSEC) Q2 2026 earnings call said it delivered record revenue and profitability. Revenue rose to $449 million, up 65% YoY, with 14% organic growth. Adjusted EBITDA was $86 million, up 98% YoY, and margin reached a record 19.2%. VSE said it closed the PAG deal May 5 (~$2B) and NorthStar on April 1, and raised full-year revenue and margin guidance.